comparemela.com
  1. Home
  2. Live Updates
  3. Molecular Therapeutics - Breaking News

Latest Breaking News On - Molecular therapeutics - Page 30 : comparemela.com

4D Molecular Therapeutics, Inc Receives FDA Regenerative Medicine Advanced Therapy Designation for 4D-150 Genetic Medicine for Intravitreal Treatment of Wet AMD, the First RMAT Designation in Wet AMD

4D Molecular Therapeutics, Inc. announced that the U.S. Food and Drug Administration has granted the RMAT designation for the investigational genetic medicine candidate 4D-150 for intravitreal.

Drug administrationD molecular therapeutics incMolecular therapeuticsCentury cures

4D Molecular Shares Rise on FDA Designation for Wet AMD Drug

By Dean Seal Shares of 4D Molecular Therapeutics rose after federal regulators granted regenerative medicine advanced therapy designation to its treatment.

David kirnDrug administrationMolecular therapeuticsExecutive david kirnDean sealArticle normalBiotechnology servicesHealthcare life sciencesBiological therapyHealthcare provisionEye conditionsPolitical general newsMedical conditionsEquity marketsCommodity financial market newsContent types

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday s Mid-Day Session - AdaptHealth (NASDAQ:AHCO), Aclarion (NASDAQ:ACON)

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

United statesGrupo supervielleJamesf lynchNir ben mosheCytokinetics incorporatedEnergy fuels incJin medical international ltdGilead sciencesBlackberry limitedIspire technology incGlobalstar incMeiragtx holdingsJin medical internationalUs worldmedsImmunovant incAclarion inc

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday s Mid-Day Session

Shares of CarMax, Inc. (NYSE:KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. KMX reported a .

United statesJamesf lynchGrupo supervielleNir ben mosheAclarion incIris energy limitedLongeveron incIspire technology incCatalyst pharmaceuticalsAurora technology acquisition corpMeiragtx holdingsCytokinetics incorporatedAnnexon incNogin incAdapthealth corpGlobalstar inc

4D Molecular Shares Rise on FDA Designation for Wet AMD Drug

By Dean Seal Shares of 4D Molecular Therapeutics rose after federal regulators granted regenerative medicine advanced therapy designation to its treatment for wet age-related macular.

David kirnDrug administrationDean sealMolecular therapeuticsExecutive david kirnDow jones

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.